PROFUSA, INC. Other Selling, General and Administrative Expense
PROFUSA, INC. (PFSA) reported Other Selling, General and Administrative Expense of $0 for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OtherSellingGeneralAndAdministrativeExpense · last filed 2025-08-14
- PROFUSA, INC. other selling, general and administrative expense for the quarter ending 2025-06-30 was $0.00.
- PROFUSA, INC. other selling, general and administrative expense for the quarter ending 2025-03-31 was $0.00.
- PROFUSA, INC. other selling, general and administrative expense for the quarter ending 2024-12-31 was $0.00.
- PROFUSA, INC. other selling, general and administrative expense for the quarter ending 2024-09-30 was $0.00.
- PROFUSA, INC. other selling, general and administrative expense for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- PROFUSA, INC. other selling, general and administrative expense for fiscal 2023 was $30.00K.
| Period end | Other Selling, General and Administrative Expense 3 month | Other Selling, General and Administrative Expense 6 month | Other Selling, General and Administrative Expense 9 month | Other Selling, General and Administrative Expense 12 month | Other Selling, General and Administrative Expense 12 month as first filed |
|---|---|---|---|---|---|
| 2025-06-30 | $0.00 10-Q · filed 2025-08-14 | $0.00 10-Q · filed 2025-08-14 | $0.00 derived: sum of 3 quarters · filed 2025-08-14 | $0.00 derived: sum of 4 quarters · filed 2025-08-14 | |
| 2025-03-31 | $0.00 10-Q · filed 2025-06-13 | $0.00 derived: sum of 2 quarters · filed 2025-06-13 | $0.00 derived: sum of 3 quarters · filed 2025-06-13 | $0.00 derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $0.00 derived: sum of 2 quarters · filed 2025-03-31 | $0.00 derived: sum of 3 quarters · filed 2025-08-14 | $0.00 10-K · filed 2025-03-31 | |
| 2024-09-30 | $0.00 10-Q · filed 2024-12-17 | $0.00 derived: sum of 2 quarters · filed 2025-08-14 | $0.00 10-Q · filed 2024-12-17 | $0.00 derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-14 | $0.00 10-Q · filed 2025-08-14 | $0.00 derived: sum of 3 quarters · filed 2025-08-14 | $0.00 derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-03-31 | $0.00 10-Q · filed 2025-06-13 | $0.00 derived: sum of 2 quarters · filed 2025-06-13 | $0.00 derived: sum of 3 quarters · filed 2025-06-13 | $15.00K derived: sum of 4 quarters · filed 2025-06-13 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $0.00 derived: sum of 2 quarters · filed 2025-03-31 | $15.00K derived: sum of 3 quarters · filed 2025-03-31 | $30.00K 10-K · filed 2025-03-31 | $15.00K 10-Q · filed 2024-10-09 |
| 2023-09-30 | $0.00 10-Q · filed 2024-12-17 | $15.00K derived: sum of 2 quarters · filed 2024-12-17 | $30.00K 10-Q · filed 2024-12-17 | ||
| 2023-06-30 | $15.00K 10-Q · filed 2024-11-15 | $30.00K 10-Q · filed 2024-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |